Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Update

Takara Bio Inc. (OTCMKTS:TKBIF) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 26,600 shares, an increase of 84.7% from the October 31st total of 14,400 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Takara Bio Stock Performance

TKBIF remained flat at $23.20 during midday trading on Thursday. The firm’s fifty day moving average is $23.20 and its 200 day moving average is $23.20. Takara Bio has a 52-week low of $23.20 and a 52-week high of $23.20.

About Takara Bio

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.